The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention
Currently, the standard treatment for patients who have undergone percutaneous coronary intervention (PCI) following acute myocardial infarction (MI) involves dual antiplatelet therapy (DAPT) with a combination of aspirin and a potent P2Y12 receptor inhibitor. However, the potential benefits of aspi...
Saved in:
| Main Authors: | Wen-Bo Dai, Jia-Yi Ren, Su-Tao Hu, Yu-Kun Zhang, Tian-Shu Gu, Xue Wu, Jing-Kun Zhang, Jing-Jin Che, Xiang-Hong Ma, Tong Liu, Guang-Ping Li, Kang-Yin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Platelets |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2024.2364748 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome
by: Wenbo Dai, et al.
Published: (2025-07-01) -
Impact of prior aspirin use on left ventricular function in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: An echocardiographic evaluation
by: Yosef Yosefzadeh, et al.
Published: (2024-09-01) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01) -
The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
by: Xiaolu Luo, et al.
Published: (2025-01-01) -
Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial
by: Xin-Yi Gao, et al.
Published: (2023-12-01)